Cargando…
Repositioning of Anthelmintic Drugs for the Treatment of Cancers of the Digestive System
Tumors of the digestive system, when combined together, account for more new cases and deaths per year than tumors arising in any other system of the body and their incidence continues to increase. Despite major efforts aimed at discovering and validating novel and effective drugs against these mali...
Autores principales: | Laudisi, Federica, Marônek, Martin, Di Grazia, Antonio, Monteleone, Giovanni, Stolfi, Carmine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404055/ https://www.ncbi.nlm.nih.gov/pubmed/32668817 http://dx.doi.org/10.3390/ijms21144957 |
Ejemplares similares
-
Anthelmintic Drugs as Emerging Immune Modulators in Cancer
por: Stolfi, Carmine, et al.
Publicado: (2023) -
Viruses in Cancers of the Digestive System: Active Contributors or Idle Bystanders?
por: Marônek, Martin, et al.
Publicado: (2020) -
STAT3 Interactors as Potential Therapeutic Targets for Cancer Treatment
por: Laudisi, Federica, et al.
Publicado: (2018) -
Impact of Food Additives on Gut Homeostasis
por: Laudisi, Federica, et al.
Publicado: (2019) -
Smad7 as a positive regulator of intestinal inflammatory diseases
por: Monteleone, Giovanni, et al.
Publicado: (2023)